PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis

PsoVac: A Psoriatic Patient-based Survey on the Understanding of the Use of Vaccines While on Biologics During the Covid-19 Pandemic

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04513847

Enrollment

661

Registered

2020-08-14

Start date

2020-08-13

Completion date

2020-10-06

Last updated

2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Psoriasis

Keywords

Education, Vaccine, Biologic

Brief summary

To determine if there is a need for further education on vaccines with psoriasis patients who are on a biologic. In regards to the COVID-19, it is important that psoriasis patients - whether on a biologic or not - understand whether they can have certain vaccines. That will depend on the type of vaccine that becomes available.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* psoriasis patient

Exclusion criteria

* no exclusions

Design outcomes

Primary

Measure	Time frame	Description
Percentage of patients not understanding the interaction of vaccines and their biologic, assessed with voluntary survey.	Data will be collected over a span of 3 months	Assessment is based upon survey responses. By answering multiple questions we will determine if more education is needed based on the answers.

Countries

Canada

Outcome results